{
  "slug": "qvin",
  "name": "Qvin",
  "description": "Qvin is a company that developed the Q-Pad, the first and only FDA-cleared diagnostic menstrual pad. It enables non-invasive, needle-free, at-home collection of menstrual blood to analyze biomarkers for various health conditions, aiming to close the women's health gap and advance medical breakthroughs.",
  "url": "https://optimly.ai/brand/qvin",
  "websiteUrl": "https://qvin.com/",
  "logoUrl": "https://logo.clearbit.com/qvin.com",
  "baiScore": 50,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Home Health Monitoring Devices",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-15T07:19:49.724Z",
  "verifiedVitals": {
    "website": "https://qvin.com",
    "what_it_does": "Qvin develops and utilizes a diagnostic menstrual pad, the Q-Pad, to collect menstrual blood for non-invasive disease diagnosis and monitoring, leveraging biomarkers found in period blood to provide health insights.",
    "core_product": "Q-Pad, an FDA-cleared diagnostic menstrual pad."
  },
  "intentTags": {
    "problemIntents": [
      "Closing the women's health gap",
      "Need for non-invasive disease diagnosis and monitoring",
      "Limitations of existing invasive sample collection methods (e.g., biopsies, needles, speculum exams)",
      "Underutilization of menstrual blood for health insights",
      "Inefficiencies in traditional lab work for health decisions"
    ],
    "solutionIntents": [
      "At-home health testing",
      "Needle-free diagnostic solutions",
      "Biomarker detection from menstrual blood",
      "Early disease detection for conditions like diabetes, cervical cancer, endometriosis, STIs, uterine fibroids",
      "Empowering women's health management through accessible diagnostics",
      "Research collaboration for menstrual blood diagnostics"
    ],
    "evaluationIntents": [
      "Q-Pad effectiveness and accuracy",
      "FDA clearance for diagnostic devices",
      "Clinical validation of menstrual blood biomarkers",
      "Partnerships for health research and funding",
      "Impact on women's health outcomes"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1789847167755
}